The effect of nevirapine on the pharmacokinetics of indinavir/ritonavir 800/100 mg BID

被引:4
作者
Burger, DM [1 ]
Prins, JM
van der Ende, ME
Aarnoutse, RE
机构
[1] Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[2] Univ Nijmegen, Ctr Infect Dis, NUCI, Nijmegen, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands
[4] Erasmus Med Ctr Rotterdam, Rotterdam, Netherlands
关键词
D O I
10.1097/00126334-200401010-00015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:97 / 98
页数:2
相关论文
共 6 条
[1]   The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers [J].
Aarnoutse, RE ;
Grintjes, KJT ;
Telgt, DSC ;
Stek, M ;
Hugen, PWH ;
Reiss, P ;
Koopmans, PP ;
Hekster, YA ;
Burger, DM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (01) :57-67
[2]   Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors [J].
Acosta, EP ;
Kakuda, TN ;
Brundage, RC ;
Anderson, PL ;
Fletcher, CV .
CLINICAL INFECTIOUS DISEASES, 2000, 30 :S151-S159
[3]   Efavirenz induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir [J].
Duval, X ;
Le Moing, V ;
Longuet, P ;
Leport, C ;
Vildé, JL ;
Lamotte, C ;
Peytavin, G ;
Farinotti, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2593-2593
[4]  
MORENO A, 2001, 41 INT C ANT AG CHEM
[5]   Drug therapy: Interactions among drugs for HIV and opportunistic infections [J].
Piscitelli, SC ;
Gallicano, KD .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (13) :984-996
[6]  
2000, PRODUCT INFORMATION